Archive


Category: $37.08M

  • Selvita to Acquire Fidelta from Galapagos for ~$37M

    Shots: Selvita to acquire 100% of the outstanding shares in Fidelta for $37.08M + customary adjustments for net cash & working capital The acquisition will expand Selvita’s integrated drug discovery services offering with the addition of Fidelta Fidelta will be fully consolidated under Selvita Group & will continue to operate under the Fidelta name. Fidelta […]